SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is actively discussed after its obesity drug's trial results did not match a key rival, leading to a significant stock dip; however, this is tempered by regulatory actions against unauthorized compounded GLP-1s and robust demand for its oral weight-loss treatment, causing a split in community sentiment between caution and buying the dip.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating significant buzz following impressive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, coupled with strong financial reporting. This has led the community to discuss "disease modifying" potential and widespread anticipation of a substantial market re-rating and short covering ahead of its investor day.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following the FDA approval of Bysanti (milsaperidone) with New Chemical Entity status and patent protection until 2044, igniting community speculation about a significant short squeeze and potential buyout offers from larger pharmaceutical firms. Investors are weighing the drug's long-term revenue potential against ongoing concerns of market manipulation and potential dilution.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining attention following news that Novo Nordisk's experimental obesity drug performed below Eli Lilly's in a Phase 3 trial, intensifying community discussions and expectations for Viking's own potentially best-in-class GLP-1/GIP assets to become a prime acquisition or partnership target in the rapidly evolving market.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending high following robust earnings and an optimistic 2026 outlook, reinforcing its leadership in the GLP-1 market, especially as a key competitor provided a weaker forecast. The community is also keenly watching its pipeline diversification through recent acquisitions and the anticipated launch of its oral weight-loss therapy.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines (UMAC) is gaining significant attention after being named a top analyst pick and securing a new $2.1 million defense order, reinforcing its crucial role as a domestic drone component supplier for the Pentagon's "Drone Dominance" initiative, while its high-profile advisory board member also sparks community discussion around potential future contracts.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent BioSolutions is trending due to recent positive developments, including a significant debt prepayment and an FDA approval for a new Narcan carrying case, though community discussion is heavily focused on a lawsuit against its former CEO which many see as a temporary dip and a strong buying opportunity ahead of anticipated robust earnings and 2026 guidance.

Polygon

Polygon is trending due to its strategic pivot towards becoming a foundational layer for payments and Real-World Assets, underpinned by recent acquisitions and record network usage driving increased token burns. Despite community frustration that its price hasn't fully reflected these developments, many are actively accumulating Polygon, citing its strong fundamentals and perceived undervaluation.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amid fresh positive news including its Huntington's disease trial approval and strong international Elevidys sales, sparking community debate over the significant undervaluation of its commercial gene therapy franchise and deep RNA pipeline ahead of upcoming earnings, especially with notable short interest.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as a pivotal player in AI infrastructure, fueled by NVIDIA's strategic investment to develop AI-native 5G and 6G networks, positioning it as an AI Edge Computing leader. The community is buzzing about its significant growth potential and undervalued status ahead of forthcoming financial updates, despite some frustration over market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phoenix Motor Inc. (19% increase in followers)Anaheim, California-based Phoenix Motor makes electric buses and trucks for various service and government fleet markets.&nbsp;This year, the company drew considerable attention after reporting encouraging fiscal third-quarter results in February that showed revenue soaring by 1,557% to $4.77 million even as net losses widened.&nbsp;After posting these results, which were delayed earlier, it regained compliance with the Nasdaq listing.In February, the company established EdisonFuture International, a Hong Kong-based subsidiary focused on expanding its EV business globally, targeting markets in the Caribbean, South America, Europe, and Asia.&nbsp;For 2024, Phoenix Motor projects revenue of $30 million to $31 million, a tenfold increase from $3 million in 2023. It expects to turn profitable after reporting a net loss in the prior year,&nbsp;with revenue for fiscal year 2025 forecasted to be in the $40 million to $50 million range.Additionally, the company's board approved a $5 million share repurchase program last week.Phoenix Motor's stock has gained 9.5% this year.Chijet Motor Company Inc. (13% increase in followers)Chijet, a Chinese developer of next-generation electric vehicles, has not had any significant news catalysts this year.&nbsp;Last month, the company received a staff determination letter from Nasdaq, notifying Chijet of its impending delisting from the Nasdaq Global Market.&nbsp;The decision came after Chijet failed to regain compliance with the exchange's minimum market value requirements: $50 million for listed securities and $15 million for publicly held shares.During its listing on the Nasdaq in June 2023, Chijet said it has a pipeline of more than a dozen new vehicles and aims to launch its FB77, a pure electric sedan, and the R9 PHEV hybrid SUV in the coming years.The company had said that future models, including the FV20, FB21, and FB31, will span both commercial and passenger segments.Chijet's stock has lost over 20% this year.Zeekr Intelligent Technology Holding (10% increase in followers)Chinese electric vehicle maker Zeekr has been making headlines this year with strong monthly delivery numbers and reports of new premium launches.&nbsp;The Geely-owned automaker's own brand sales surged 86.9% year-over-year in February, and the recent Lynk &amp; Co acquisition boosted total deliveries.&nbsp;Zeekr is also set to unveil the ultra-luxury 9X Grand SUV this month in China, targeting high-end consumers and taking on brands like Mercedes-Benz and BMW.Zeekr stock has lost over 13% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Visitors check ZEEKR 7X cars displayed at the 46th Bangkok International Motor Show 2025 in Nonthaburi province on the outskirts of Bangkok, Thailand, on March 28, 2025. (Photo by Anusak Laowilas/NurPhoto via Getty Images)

Phoenix Motor, Chijet, Zeekr: Retail Traders Flocked To These 3 Auto Stocks The Most In Q1

Although companies such as Tesla, Rivian and legacy automakers such as Ford and GM have dominated headlines this year, these lesser known brands captivated Stocktwits users more in Q1 2025. 

Equity

These five automobile-linked stocks notched the biggest jump in retail following on Stocktwits in the week ended Feb. 14, 2025:WeRide Inc. (+460% jump in following)Chinese self-driving startup WeRide surged to a record high after an SEC filing&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wrd-stock-hits-record-high-on-nvidia-stake/ch5iISdRHD">revealed</a> that AI chip giant Nvidia had taken a stake, owning 1.7 million shares.&nbsp;According to The Fly, Morgan Stanley called the move a sign of growing investor enthusiasm for self-driving technology and the value of strategic alliances in the robotaxi space. The research firm has an 'Overweight' rating and a $23 price target on the stock, which is up 122% year-to-date (YTD).Phoenix Motor Inc. (+14% jump in following)Phoenix Motor regained Nasdaq compliance after resolving delays in its SEC filings, giving the stock a lift. Earlier in the week, the company posted fiscal third-quarter revenue of $4.8 million, up sharply from just $0.2 million a year earlier. It cited the successful integration of its transit segment and partnerships in AI and autonomous tech.&nbsp;Shares are up 25% YTD.Strattec Security Corporation (+8% jump in following)Auto security supplier Strattec continued its rally, likely fueled by strong earnings earlier in the month. Fiscal second-quarter net sales rose 9.6% to $129.9 million, beating estimates, driven by new program launches and rising volumes from key customers like GM and Ford. While sales to Stellantis lagged, demand was strong in North America, particularly from Hyundai.Shares are up nearly 19% YTD.Hesai Group (+5% jump in following)Lidar maker Hesai announced a deeper collaboration with Chinese EV giant BYD, providing lidar for more than 10 upcoming BYD models set for mass production in 2025. BYD, which sold over 4 million intelligent-driving-equipped vehicles last year, is integrating Hesai’s lidar into its next-gen “God’s Eye” ADAS system, expected to expand self-driving features across its lineup.&nbsp;Hesai’s stock is up over 29% YTD.Motorcar Parts of America (+2.5% jump in following)Motorcar Parts reported strong fiscal Q3 results as it swung to a profit, with revenue rising to $186.2 million from $171.9 million last year. CEO Selwyn Joffe highlighted the company’s leadership in the non-discretionary aftermarket parts sector and its focus on quality and customer service.&nbsp;Shares are up 24% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the WeRide, Inc. logo is displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Top 5 Auto Stocks That Had Retail Traders Revved Up Last Week

From AI giants taking a stake to earnings beats, these auto-linked stocks saw the biggest surge in new Stocktwits followers.

Phoenix Motor, Inc. designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium duty electric vehicles, with an aim to reduce carbon intensity and greenhouse gas emissions. It operates under the brands Phoenix Motorcars, which is focused on commercial products including medium duty electric vehicles, chargers, and electric forklifts, and EdisonFuture, which intends to offer light-duty electric vehicles. The company was founded in 2003 and is headquartered in Anaheim, CA.

PEV
Phoenix Motor Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PEV News

PEV Phoenix Motor Inc